This case-control study was designed to investigate association between polychlorinated biphenyls (PCBs) and risk of breast cancer in an area of high environmental exposure in the Michalovce district of eastern Slovakia. Incident breast cancer cases from the Michalovce district diagnosed between May 1997 and May 1999 were recruited through the Oncology Department of the District Hospital. A total of 15 individual PCB congeners, 2,2 0 -bis(4-chlorophenyl)-1,1-dichloroethylene (DDE), 2,2-bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT), and hexachlorobenzene (HCB) were measured in the serum of 24 breast cancer patients and 88 population controls in 1998-1999. The median levels of total PCBs were similar in cases (2586 ng/g of lipid) and controls (2682 ng/g of lipid). Higher serum levels (highest vs. lowest tertile) of total PCBs (odds ratio (OR) ¼ 0.42, 95% CI 0.10-1.82, p-for trend ¼ 0.31), group 1 congeners (OR ¼ 0.37, 95% CI 0.10-1.43, P-for trend ¼ 0.02), group 2 congeners (OR ¼ 0.32, 95% CI 0.07-1.56, P-for trend ¼ 0.60), and group 3 congeners (OR ¼ 0.49, 95% CI 0.12-2.04, P-for trend ¼ 0.51) were inversely associated with risk of breast cancer. Higher serum levels of DDE (OR ¼ 3.04, 95% CI 0.65-14.3, P-for trend ¼ 0.10) were positively associated with risk of breast cancer, while there was no association for DDT (OR ¼ 1.19, 95% CI 0.27-5.23, P-for trend ¼ 0.68), and an inverse association for HCB (OR ¼ 0.45, 95% CI 0.06-3.19, P-for trend ¼ 0.67). While generally not statistically significant, PCB and HCB levels were inversely associated with risk of breast cancer in this highly exposed population. DDE, but not DDT, was positively associated with risk.
Introduction
In the United States, polychlorinated biphenyls (PCBs), 2,2-bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT) and related organochlorine compounds were widely used in various industrial applications and as pesticides until banned in 1977 and 1972, respectively. Production and use in Central and Eastern Europe continued until the mid-1980s. Between 1959 mid-1980s. Between and 1984 ,000 tons of PCBs were produced by the Chemko Strazske chemical plant in the Michalovce district of eastern Slovakia, the only production facility in Slovakia manufacturing PCBs. Contamination of the environment and food chain was recently documented with PCB levels three to hundred times higher in the Michalovce district than in the comparison Stropkov district . PCB levels two to three times higher than in other parts of Slovakia were also found in a small number of milk and blood samples (Kocan et al., 1994; Petrik et al., 2001) .
Lipophilicity and resistance to degradation leads to bioaccumulation of these compounds in the food chain and in human adipose tissue, blood lipids and breast milk (Hansen, 1987; Patterson et al., 1994) . PCBs and DDT analogs have been implicated as risk factors for breast cancer because of their potential to act as direct or indirect carcinogens (Safe, 1989; Ahlborg et al., 1995; Cogliano, 1998) , their estrogenic and antiestrogenic properties (Bulger et al., 1983; McKinney and Waller, 1994; Brouwer et al., 1999) , their ability to induce cytochrome p450 enzymes (Safe, 1994) , and their alteration of mammary gland differentiation and proliferation (Brown and Lamartiniere, 1995) .
Findings from epidemiologic studies examining the association between organochlorine compounds and breast cancer have been inconsistent. Most of the recent prospective cohort and case-control studies have not found overall significant associations supporting the hypothesis that exposure to PCBs and DDE increases the risk of breast cancer (Hunter et al., 1997; Lopez-Carrillo et al., 1997; van't Veer et al., 1997; Hoyer et al., 1998; Dorgan et al., 1999; Helzlsouer et al., 1999; Zheng et al., 1999a; Holford et al., 2000; Stellman et al., 2000; Ward et al., 2000; Wolff et al., 2000; Zheng et al., 2000; Laden et al., 2001a, b; Woolcott et al., 2001; Gammon et al., 2002; Lopez-Carrillo et al., 2002) . No elevated risk of breast cancer associated with PCB and 2,2 0 -bis(4-chlorophenyl)-1,1-dichloroethylene (DDE) was observed in the largest prospective American study where analyses of organochlorines in stored blood from 1970s were available (Helzlsouer et al., 1999) . Prospective studies in United States (Hunter et al., 1997; Laden et al., 2001a) , in Norway , and in Denmark (Hoyer et al., 1998) observed nonsignificant inverse associations with PCB and DDE levels and risk of breast cancer.
In contrast, earlier prospective studies in New York (Wolff et al., 1993) and the San Francisco Bay area found a significant increase in the risk with higher serum levels of DDE and a nonsignifcant positive association with PCBs, as well as a nonsignificant elevated risk associated with DDE among African-Americans and white subjects (Krieger et al., 1994) . A prospective study in Missouri found a suggested increased risk for PCB congeners 118 and 138 (Dorgan et al., 1999) . Two case-control studies in western New York observed increased risk for parous women who never lactated (Moysich et al., 1998) and for women with higher PCB levels and a CYP1A1 polymorphism (Moysich et al., 1999) . A recent study in Connecticut reported adverse effect of PCBs 180 and 183, phenobarbital, CYP1A1 and CYP2B1 inducers, and protective effect of PCB 156, a potentially antiestrogenic congener, on risk of breast cancer . Elevated risk among premenopausal women was observed for PCB congeners 105 and 118, and for congeners 170 and 180 among postmenopausal women in a Canadian study comparing adipose tissue levels from breast cancer cases and benign breast disease controls (Aronson et al., 2000) . In addition, a recent case-control study from the Quebec region found statistically significant associations between breast cancer risk and levels of PCBs 118 and 156 and with a total concentration of the three mono-ortho substituted congeners 105, 118 and 156 expressed as 2,3,7,8-tetrachorodibenzo-p-dioxin toxic equivalents (Demers et al., 2002) .
Most studies published to date have evaluated exposure at low environmental levels of PCB and DDE contamination. In this study, we focus on the initial characteristics of breast cancer cases coming from an area with environmental exposure to PCBs that was 3-10 times higher than reported in previous studies. Geometric mean levels of PCB and DDE in this study were 2886 and 3129 ng/g of lipid, respectively, or alternatively approximately 20.6 and 22.4 ng/ml wet weight (adipose/140 ¼ serum, Wolff et al., 2000) . In comparison, PCB levels in five American studies recently reviewed by Laden et al. (2000b) ranged between 3.63 and 4.98 ng/ml for PCBs (530-670 ng/g of lipid), and from 2.63 to 11.13 ng/ml for DDE (410-1150 ng/g of lipid). Levels of PCBs in stored blood from 1970s in Denmark and Sweden were 7.8 ng/ml (1100 ng/g lipid) and 5.1 ng/ml (806 ng/g lipid), respectively. A recent Canadian study that measured similar PCB congeners as our study found a PCB level of 193 ng/g of lipid or approximately 1.4 ng/ml.
Methods

Study population
In June 1999, we identified 37 primary, histologically confirmed breast cancer cases, with no previous cancer history, and diagnosed between May 1997 and May 1999 through the Oncology Department and Clinic of the District Hospital in Michalovce. Three of the 37 eligible women were deceased, 24 (71%) accepted an invitation for a preventive check-up at the clinic and agreed to participate in this study, and 10 did not respond to the invitation. Nonparticipants were of similar age and had been on similar treatment regimes as those who participated. The Oncology Department is the only specialized cancer diagnostic and treatment center in the district, and primary care physicians refer most patients from the district to this facility. Health insurance in Slovakia is required by law and coverage is shared by an employee and employer. The state provides coverage for children, unemployed, and retired citizens. According to data collected by the National Cancer Registry, no more than 40 breast cancer cases were expected over this 2-year period taking into account year-to-year fluctuations in number of cases, thus the 37 patients identified represent approximately 92% coverage (Plesko et al., 1985 (Plesko et al., -1994 . All cases were residents of the Michalovce district for at least 10 years.
Controls were participants in a cross-sectional study we conducted in the Michalovce district in 1998 with the aim to characterize serum PCB levels in the general population of this district. Individuals aged 18-80 years with at least 10 years of residence in the district were selected through a systematic random sampling of a priori selected primary care physicians (selection based on location in the district). Nine out of 42 primary care physicians from the Michalovce district were asked to participate. Physicians with less than 1300 patients were asked to recruit 20 subjects and those with more than 1300 patients to recruit 30 subjects. Each physician also selected a reserve pool of five patients to serve as replacements for selected patients who chose not to participate. In all, 215 patients (110 males, 105 females) from the Michalovce district were recruited. After exclusion of women with prevalent cancers as indicated by their physicians, 88 female controls from the Michalovce district remained. Cases and controls from the Michalovce district that participated in the study came from the same geographically defined area of the district.
Cases in 1999, and controls in 1998, were administered an identical face-to-face questionnaire by the same interviewers, and donated 18 ml of blood after signing an informed consent document. The questionnaire contained items addressing personal and demographic data, smoking, alcohol consumption, consumption of selected food items, a brief occupational history, and personal medical and reproductive histories. A medical history for each participant was also obtained from her primary care physician that included diagnostic and treatment procedures. All cases had undergone surgical treatment of their breast cancer before donating blood. Five women were currently on chemotherapy regiment of cyclophosphamid, methotrexate, and 5-fluorouracil, and two women received 5-flourouracil, adriamycin, cyclophosphamid combination. Nine women had finished their chemotherapy at least 3 months before the time of blood collection on similar combinations. A total of 18 women had also had radiotherapy. Two women received hormonal therapy (Zoladex) and no chemotherapy.
Laboratory Methods
Whole blood was collected from fasting subjects in two 9 ml vacutainer tubes (S-Monovette, Sarstedt, Germany) without anticoagulants and immediately centrifuged at 3000 rpm for 15 min. Serum was aliquoted into glass tubes and frozen at À181 C until time of analysis. The Department of Toxic Organic Pollutants at the Institute of Preventive and Clinical Medicine, Bratislava, Slovakia, performed the laboratory analyses. Concentrations of 15 environmentally prevalent PCB congeners (International Union of Pure and Applied Chemistry numbers: 28, 52, 101, 105, 114, 118, 123, 138, 153, 156, 157, 167, 170, 180, and 189) 
, and hexachlorobenzene (HCB) were determined in serum samples by highresolution gas chromatography.
Details of laboratory procedures for analyzing PCBs in blood serum have been described elsewhere (Kocan et al., 1994) . The method uses hexane extraction of organochlorine compounds with subsequent concentration and clean up on combined Florisil-silica gel column (US Silica Co., Berkeley Springs, WV, USA). A high-resolution gas chromatography system (HP 5890, Hewlett-Packard, Palo Alto, CA, USA), equipped with a Ni-63 electron capture detector, was used for identification and quantification of the organochlorine pesticides and PCB congeners. Identification of peaks of PCB congeners and chlorinated pesticides was based on comparison of chromatographic retention times relative to external standards. In accordance with internal quality control rules, blank and recovery samples (olive oil spiked with known amount of PCB congeners) were run in every batch of samples. The limit of detection for each analyte was determined as the mean of background noise plus three standard deviations from five reagent blank samples. Limits of detection ranged from 0.21 ng/g of lipid for PCB congener 167 to 1.47 ng/g of lipid for congener 52. For organochlorine pesticides, the range was between 1 and 4 ng/g of lipid.
Average percentage recoveries of organchlorines extracted from serum ranged from 95% to 112% for PCBs and between 91% and 117% for chlorinated pesticides. Control samples were analyzed between November 1998 and February 1999, breast cancer cases samples between October and November 1999. In 1998, coefficients of variations ranged between 5.6% and 15.4% for PCB congeners, and between 9.2% and 16.2% for organochlorine pesticides. In 1999, the coefficients ranged between 4.5% and 13.2% for PCBs, and between 5.7% and 14.1% for organochlorine pesticides. No consistent way of dealing with values below the detection limit is given in literature . Participants with undetectable levels in this study were assigned half of the concentration of the limit of detection for the individual PCB congener. All concentrations are presented in ng/g of lipid. The amount of lipid in the sample was quantified gravimetrically. The laboratory is certified by WHO and by the German Society for Occupational and Environmental Medicine for analysis of polychlorinated biphenyls in milk and blood (WHO, 2000) .
Statistical Analysis
We used the classification originally proposed by Wolff et al. (1997) , slightly modified using data by Hansen et al. (1998) , and assigned PCB congeners into three groups to better distinguish their structure activity related toxicologic properties. Group 1 consisted of Wolff's combined groups 1a and 1b, and was represented by PCBs 28 and 101. We chose not to include congener 52 in the analysis since 54% of the cases had levels below the limit of detection (LOD). These congeners are estrogenic, not persistent, and weak phenobarbital-inducers. Group 2 included mono-ortho substituted congeners from Wolff's group 2a (PCBs 105, 118, 156, and 167) and mono-ortho substituted congeners 114, 123, 157, and 189 that were measured in our samples. These congeners are antiestrogenic, dioxin-like, immunotoxic, and moderately persistent. Group 3 included congeners 138 and 170 (originally Wolff's group 2b) in addition to congeners 153 and 180 (originally Wolff's group 3). All these congeners are persistent, di-ortho substituted, and stronger phenobarbitaltype than methylchlorantrene-type inducers. Levels of potentially estrogenic congeners (group 1) were weakly correlated with group 2 (r ¼ 0.12) and group 3 (r ¼ 0.13) congeners. Group 3 was highly correlated with total PCBs (r ¼ 0.95) and with group 2 (r ¼ 0.67). Exposure to DDE and HCB was modestly correlated with total PCB levels (r ¼ 0.34 and 0.25, respectively).
Geometric means and medians were calculated for total PCBs, groups of PCBs and other organochlorines. The log-transformed values of total PCBs, DDE, DDT, and HCB exhibited a normal distribution and we used analysis of covariance to compare means of log-transformed serum levels concentrations of these compounds with age at the time of blood collection included as a continuous covariate.
Odds ratios (OR) for breast cancer risk were estimated using unconditional logistic regression. Exposure variables (PCBs and organochlorines) were categorized into strata based on tertiles of their respective distribution in the controls. We evaluated confounding by adjusting the OR for age, height, body mass index (BMI), number of full-term pregnancies, menopausal status, age at menarche, alcohol consumption, smoking, marital status, and education. Covariates selected for the final models were either significant at po0.05 and/or changed the observed OR by more than 10%. The p-values in tests for trend were obtained from logistic models by entering indicator variable with values 0, 1, 
Results
The risk of breast cancer was positively associated with a greater BMI, not being married, an earlier age at menarche, nulliparity, postmenopausal status, never lactating, alcohol abstinence, and ever smoking (Table 1) . Education was inversely associated with the risk of breast cancer. Median age for controls was 46.0 years (range 18-78) and 51.5 years for cases (range 26-73).
Median levels for all three groups of PCB congeners and total PCB levels ( Table 2) were lower in cases than in controls. After adjustment for age at blood collection, cases and controls did not differ significantly in geometric mean levels of total PCBs, or in group 2 and group 3 PCB congeners. However, cases had significantly lower levels of estrogenic group 1 PCB congeners (P ¼ 0.004).
Levels of DDE and DDT were statistically significantly higher in cases (P ¼ 0.04 and 0.03, respectively) compared to controls. HCB levels were also elevated for cases, but the difference was not statistically significant (P ¼ 0.53). No occupational exposure to PCBs and organochlorine pesticides was identified in either cases or controls.
The risk of breast cancer (Table 3 ) decreased with increasing levels of PCBs in group 1 congeners (OR ¼ 0.34, 95% CI 0.08-1.51; and OR ¼ 0.22, 95% CI 0.05-0.99) and the test for trend was statistically significant (P ¼ 0.02). Three control subjects excluded from the analysis for missing covariates values. c Odds ratios (ORs) adjusted for age, age at menarche, education (r8, 9-10, >10 years), alcohol consumption (0, 1-3, >3 drinks a week), and pack-years of smoking.
Organochlorines and risk of breast cancer
Pavuk et al.
Similar, inverse, but statistically nonsignificant associations were observed for group 2, group 3, and total PCBs. None of the three organochlorine pesticides, including DDE, DDT, and hexachlorobenzene, was associated with statistically significantly increased or decreased risk of breast cancer (Table 4) . However, the OR for cases in the third tertile of DDE distribution was nonsignificantly increased (OR ¼ 3.04, 95% CI 0.65-14.3). Also, when DDE was modeled as a log-transformed continuous indicator variable, the association was statistically significant (OR ¼ 2.41, CI 1.04-5.58). The direction and magnitude of all reported associations did not change appreciably (except for less precise CIs) when analyses were limited to postmenopausal women only.
Discussion
Results observed in this case-control study conducted in an area of high environmental exposure to PCBs are consistent with recent large prospective cohort and case-control studies that have shown little or no evidence of a positive association between organochlorines body burden with the risk of breast cancer in populations with low PCB levels. However, we must bear in mind the small sample size and, therefore preliminary conclusions of this study.
We report slightly lower total and group 2 and 3 PCB levels in breast cancer cases than in controls. However, the levels of putative estrogenic, low-persistence PCB congeners (group 1) were about 40% lower in cases, and we did observe statistically significant inverse association for this group of congeners. This suggests that this least persistent group of PCB congeners may not well reflect the levels at the time of the chemical insult, but rather more recent change in exposure and intake in cases, for example, more profound change in dietary habits after the breast cancer diagnoses. Inverse trends in the OR for total PCBs reported here have been observed previously in some other studies (Helzlsouer et al., 1999; Laden et al., 2000a,b) . In contrast, levels of DDE and DDT were 50-60% higher in breast cancer cases, and the suggestive positive association with DDE should be examined in larger study. We found a statistically nonsignificant inverse association between breast cancer risk and levels of HCB, consistent with two previous reports (Moysich et al., 1998; Zheng et al., 1999b) .
Our ability to examine the association between organochlorine levels and breast cancer at levels five to ten times higher than those measured in recent studies is one of the strengths of our study (Stellman et al., 2000; Wolff et al., 2000; Laden et al., 2001b) . PCB and DDE levels were also more than three times higher than the highest levels reported in studies where samples were collected in 1970s (Hoyer et al., 1998; Helzlsouer et al., 1999; Ward et al., 2000) . Most of the analytes measured here had over 95% of the results above the limit of detection, and we were also able to determine levels of nonpersistent PCB congeners 28, 52, and 101. Besides total PCB levels, we assessed the relationship between breast cancer risk and PCB congeners grouped into three toxicologic groups based on their structure-activity properties, and we observed inverse associations for all groups. While a positive association might be expected for group 1 or for individual congeners in this group, congeners 28 and 52 were both inversely related to the risk of breast cancer, while congener 101 was not related to risk (data not shown). Exclusion of congener 52 from group 1 did not change the strength or direction of the observed association. We also examined the association between some individual congeners, specifically PCBs 118, 138, 153, 156 , and 180, but we did not find associations with the risk of cancer as suggested by some previous studies, and those results were not presented here Three control subjects excluded from the analysis for missing covariates values. c Odds ratios (ORs) adjusted for age, age at menarche, education (r8, 9-10, >10 years), alcohol consumption (0, 1-3, >3 drinks a week), and pack-years of smoking.
Organochlorines and risk of breast cancer Pavuk et al. (Dorgan et al., 1999; Aronson et al., 2000; Demers et al., 2002; Holford et al., 2000) .
A limitation of the study is that cases and controls had their organochlorine levels assayed separately, 9 months apart. However, the analyses were performed in the same laboratory, with the same protocol, personnel, equipment, and quality assurance/control procedures. The laboratory is WHO certified for analysis of PCBs and regularly participates in interlaboratory validation studies. However, laboratory technicians were not blind to case status. In addition, while this study measured levels of 15 PCB congeners at relatively high levels, levels of potent antiestrogenic non-ortho or coplanar PCB congeners 126, 169, 81, or 37, or additional mono-ortho and di-ortho congeners were not measured. Thus, the total estrogenic and antiestrogenic activity is not known and limits the inferences we can make. Measurement of dioxin and dibenzofuran congeners that could have been unintentional by-products of PCB production and also exhibit antiestrogenic properties should be considered in future studies.
There is little doubt that the most likely explanation for high PCB body burdens in women from the Michalovce district was the presence of the PCB production facility. Large amounts of PCBs were released into the environment over the decades of PCB production resulting in contamination of water, sediments, soil, and the food chain . Extensive use of DDT and DDT-based pesticides, before their ban in mid-1980s, may explain high levels of DDE in our study subjects. Hexachlorobenzene (HCB) was never intentionally produced in this chemical plant but may have been a by-product in production of other chemicals.
Cases and controls in our study differed with respect to most established breast cancer risk factors, and positive associations were observed for a greater BMI, an earlier age at menarche, never lactating, postmenopausal status, alcohol abstinence, and ever smoking. Higher education was not associated with higher risk. The study was community-based, and conducted in a very stable population with a median time of residency exceeding 35 years. BMI and lactation have been shown to be associated with organochlorine concentrations (Rogan et al., 1987; Jensen, 1988; Kelsey et al., 1993) . Among controls in our study, neither BMI nor the length of lactation was significantly associated with serum PCBs or organochlorine pesticides levels, and they did not appear to confound the association between organochlorines and risk of breast cancer. A majority of the women in our study lactated more than 20 years before their blood was collected, so the effect of lactation on reduction of serum organochlorine levels would be hard to detect. Consistent with other studies, older age was associated with higher organochlorine levels in our study. In addition, controls were on average 5 years younger than cases, and therefore all our analyses required careful adjustment for age.
We did not attempt to frequency match on menopausal status, and 80% of our breast cancer cases were postmenopausal in contrast to 41% controls. Although some risk factors for breast cancer appear to be different for premenopausal and postmenopausal women, when our analyses were restricted only to postmenopausal women, there was no substantial change in our results. We attempted to reduce volunteer bias by using the Oncology Department to invite the identified breast cancer cases to attend a preventive check-up at the outpatient clinic instead of inviting them to participate in our study. We had a previous experience with patients in the district responding well to an invitation from their physicians. Differences in recall between cases and control were minimized by using the same standardized questionnaire administered by the same group of trained interviewers. Since levels of PCBs and other organochlorines were measured as a biomarker, this makes observation bias unlikely. Taking into account the yearto-year variation in the incidence of breast cancer in the Michalovce district, the coverage and identification of cases by the Oncology department was quite high. However, we do not know whether the cases that refused to participate died, or were not identified differed systematically from the study participants.
The retrospective design of our study, small sample size, and the single measurement of serum organochlorine levels in blood samples obtained 3-20 months after the breast cancer diagnosis limit the inferences that can be made from our results. Measurements of organochlorine levels in most of our cases were performed after surgery and chemotherapy and/or radiation therapy. We could not assess the effects these treatment procedures on PCB levels and compare them to levels measured several years before the diagnosis. A smaller study suggested that organochlorine levels may change during chemotherapy (Gammon et al., 1996) , while others did not observed any significant changes . Current levels of PCB congeners and other organochlorines may also not reflect the levels of these compounds at the time of chemical insult. Recently, more precise estimates of PCB mixture half-lives were obtained (Wolff et al., 2000) , which could provide better approximation of the PCB levels at that time and could be used in future studies. Individual levels are also influenced by the induction of biotransformation enzymes by these compounds (e.g. CYP1A, 1B, 2B etc.) and possibly by genetic polymorphisms in these enzymes (Moysich et al., 1999; Pang et al., 1999; Daly, 2003) . All these factors and different sensitivity to these exposures in utero, early childhood, adolescence, and adulthood may have different effect on development of breast cancer. A prospective design would allow for a much stronger examination of these types of associations.
Recent epidemiologic studies linking organochlorine exposure to breast cancer have produced growing evidence suggesting that low levels of organochlorines are only weakly or not at all associated with breast cancer risk; some studies have shown inverse associations. Results of present casecontrol study examined these associations in population highly exposed to PCBs, DDE, and HCB. While suggestions of inverse trends were found for PCBs, significantly higher DDE levels were found in breast cancer cases. The nature and magnitude of PCB and DDE exposures in this population makes it unique and valuable source of research material for future systematic studies of possible association between organochlorines and cancer.
